Hong Liao
China Pharmaceutical University(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments, Psoriasis: Treatment and Pathogenesis
Most-Cited Works
- → High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma(2011)95 cited
- → Interleukin‐17 gene polymorphisms are associated with bladder cancer in a chinese han population(2012)49 cited
- → Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer(2015)27 cited
- → Prognostic value of PDCD6 polymorphisms and the susceptibility to bladder cancer(2014)9 cited
- → Design, Synthesis, and Biological Evaluation of Eukaryotic Initiation Factor 2B (eIF2B) Activators(2024)1 cited
- Detection and treatment of Giardia lamblia infection in children with chronic abdominal pain(2009)
- → Expression and clinical significance of lymphoma-associated macrophages (CD68 positive cells) in the matrix of follicular lymphoma(2011)
- → Diagnosis and treatment of primary renal lymphoma: report of one case and review of literature(2017)
- Therapeutic efficacy and prognostic analysis of relapsed NK/T cell lymphoma(2008)
- The roles of metformin in anti-tumor therapy.(2010)